Related Experiment Video
Updated: Jun 12, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions
Kazuko Okamoto-Shibayama1, Yutaka Sato, Toshifumi Azuma
1Department of Biochemistry and Oral Health Science Center HRC7, Tokyo Dental College, Mihama-ku, Chiba City, Japan. okamotok@tdc.ac.jp
Abstract:
The ability of the human fungal pathogen Candida albicans to undergo the morphological transition from a single yeast form to pseudohyphal and hyphal forms in response to various conditions is known to be an important for its virulence. Many studies have shown the pharmacological effects of resveratrol, a phytoalexin polyphenolic compound. In this study, we investigated the antifungal activity of resveratrol against C. albicans. Both yeast-form and mycelial growth of C. albicans were inhibited by resveratrol. In addition, normal filamentation of C. albicans was affected and yeast-to-hypha transition under serum-, pH-, and nutrient-induced hyphal growth conditions was impaired by resveratrol.
Insights
Resveratrol, a natural compound, effectively inhibits the growth and virulence of Candida albicans, a common fungal pathogen. This study shows resveratrol disrupts key fungal development, offering potential for new antifungal therapies.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Background:
- Candida albicans is a human fungal pathogen whose virulence is linked to its morphological transition from yeast to hyphal forms.
- Resveratrol, a polyphenolic compound found in plants, has demonstrated various pharmacological effects, including potential antimicrobial properties.
Purpose of the Study:
- To investigate the antifungal activity of resveratrol against Candida albicans.
- To determine if resveratrol affects the morphological transition of C. albicans.
Main Methods:
- Culturing of Candida albicans in yeast and mycelial forms.
- Treatment of C. albicans cultures with varying concentrations of resveratrol.
- Microscopic observation and growth assays to assess fungal morphology and growth inhibition.
Main Results:
- Resveratrol significantly inhibited both yeast-form and mycelial growth of C. albicans.
- Resveratrol impaired the yeast-to-hypha transition of C. albicans under various inducing conditions (serum, pH, nutrients).
- Normal filamentation of C. albicans was disrupted by resveratrol treatment.
Conclusions:
- Resveratrol exhibits potent antifungal activity against Candida albicans.
- Resveratrol interferes with the crucial morphological transition of C. albicans, suggesting a mechanism for its virulence inhibition.
- Resveratrol represents a promising candidate for the development of novel antifungal strategies against C. albicans infections.
More Related Videos
09:24Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host
Published on: October 12, 2022
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Related Concept Videos
Candidiasis
Fungal Group Zygomycota